Skeletal muscle mass responds rapidly to growth stimuli, precipitating hypertrophies (increased protein synthesis) and hyperplasia (activation of the myogenic program). For ages, muscle degeneration has been attributed to changes in the intracellular myofiber pathways. These pathways are tightly regulated by hormones and lymphokines that ultimately pave the way to decreased anabolism and accelerated protein breakdown. Despite the lacunae in our understanding of specific pathways, growing bodies of evidence suggest that the changes in the myogenic/regenerative program are the major contributing factor in the development and progression of muscle wasting. In addition, inflammation plays a key role in the pathophysiology of diseases linked to the failure of skeletal muscles. Chronic inflammation with elevated levels of inflammatory mediators has been observed in a spectrum of diseases, such as inflammatory myopathies and chronic obstructive pulmonary disease (COPD). Although the pathophysiology of these diseases varies greatly, they all demonstrate sarcopenia and dysregulated skeletal muscle physiology as common symptoms. Medicinal plants harbor potential novel chemical moieties for a plenitude of illnesses, and inflammation is no exception. However, despite the vast number of potential antiinflammatory compounds found in plant extracts and isolated components, the research on medicinal plants is highly daunting. This review aims to explore the various phytoconstituents employed in the treatment of inflammatory responses in skeletal muscles, while providing an in-depth molecular insight into the latter.
To overcome the hazardous effects on liver caused by long-term use of antitubercular agent isoniazid (INH) by developing a novel hepatoprotective prodrug strategy by conjugating INH with aminothiols as antioxidant promoities for probable synergistic effect. INH was conjugated with N-acetyl cysteine (NAC) and N-(2)-mercaptopropionyl glycine using the Schotten-Baumann reaction and with L-methionine using Boc-anhydride through a biocleavable amide linkage. Synthesized prodrugs were characterized by spectral analysis, and in vitro and in vivo release studies were carried out using HPLC. Their hepatoprotective potential was evaluated in male Wistar rats by performing liver function tests, measuring markers of oxidative stress and carrying out histopathology studies. Prodrugs were found to be stable in acidic (pH 1.2) and basic (pH 7.4) buffers and in rat stomach homogenates, whereas they were hydrolysed significantly (59.43%-94.93%) in intestinal homogenates over a period of 6 h. Upon oral administration of prodrug NI to rats, 52.4%-61.3% INH and 47.4%-56.8% of NAC were recovered in blood in 8-10 h. Urine and faeces samples pooled over a period of 24 h exhibited 1.3%-2.5% and 0.94%-0.9% of NAC, respectively, without any presence of intact NI or INH. Prodrugs were biologically evaluated for hepatoprotective activity. All the prodrugs were effective in abating oxidative stress and re-establishing the normal hepatic physiology. The effect of prodrug of INH with NAC in restoring the levels of the enzymes superoxide dismutase and glutathione peroxidase and abrogating liver damage was noteworthy especially. The findings of this investigation demonstrated that the reported prodrugs can add safety and efficacy to future clinical protocols of tuberculosis treatment.
Aim: The research work aims to develop a sustainable microwave-assisted scheme for the synthesis of 4-(benzylidene amino)-6-phenylpyrimidine-5-carbonitrile congeners. Background: 4-(benzylidene amino)-6-phenylpyrimidine-5-carbonitrile scaffolds are novel molecules having various pharmacological activities, such as neurodegenerative, antimicrobial, and anticancer. Schiff base congeners are considered efficient pharmacophores for research. These activities are due to the presence of azomethine (CH=N) group in the Schiff base compounds. Objectives: The aim of the study was to synthesise different novel Schiff base scaffolds of pyrimidine nuclei by green chemistry in good yield. Methods: The 4-(benzylidene amino)-6-phenylpyrimidine-5-carbonitrile scaffolds were prepared by two-step reactions. Both steps were microwave-assisted. The first step was to synthesize 4-amino-6- phenylpyrimidine-5-carbonitrile as an intermediate compound. This compound was synthesized by using benzaldehyde, malononitrile and formamidine hydrochloride. The reaction conditions are as follows: temperature- 101°C, pressure- 300W, time- 50min. The final Schiff base congeners were obtained by reacting them with various aromatic aldehydes in the second step. The yield, reaction condition, and time consumption were all very acceptable for the green synthetic methods rather than the conventional schemes. Results: Microwave-assisted method was more efficient. The reactions were less time-consuming, and the overall yield of the all-synthesized compounds was in the range of 72-81%. The synthesized congeners were characterized by different spectroscopic methods. The main functional group, azomethine, was considered by the IR peak at 1611 cm-1 wavelength. Conclusions: This microwave-assisted synthetic method thus emerges as more eco-friendly due to a much-reduced usage of organic solvents, leading to less harmful residues. Using this scheme, we synthesized different Schiff base congeners with satisfactory chemical yields.